Together, our data indicate that IDO1 is mainly expressed in tumor endothelial cells of B16-F10 and HCmel12 melanomas and that its expression can be further enhanced by agonistic CD40 mAb therapy and the associated IFNγ expression in the tumor microenvironment. The gene discussed is IFNG; the disease is neoplasm.